Skip to content
close icon

Adjunctive Therapy in Focal-Onset Seizures

NO LONGER ACCEPTING APPLICATIONS
Published on:
March 10, 2025
Sign-up Expiration:
Updated:
Topics:
Neurology
Dr. Robert Nahouraii
Dr. Michael Amiri
Brain Disease
Epilepsy
Seizures
Locations:
Charlotte, NC
Dr. Robert Nahouraii
Dr. Michael Amiri

This is a Phase 3, randomized, double blind, placebo-controlled study to evaluatethe clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive treatment in adult subjects 18 years of age or older from different geographic regions, diagnosed with focal epilepsy and taking 1 to 3 ASMs (Anti-Seizure Medicine/Medication). Compared to a placebo on reducing focal seizure frequency. Single daily dose of an immediate release capsule for 84 days.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED

Other Enrolling Clinical Trials

View All Enrolling Trials
Systemic Lupus Erythmatosus

This study is to demonstrate efficacy of litifilmab compared with placebo in participants with active SLE, who are receiving background lupus standard of care therapy in reducing disease activity.

View Trial
Tourette's Disorder

Efficacy and safety of gemlapodect in adults and adolescents with Tourette Syndrome.

View Trial
Pediatric Patients with Insomnia Disorder

To evaluate the efficacy of tasimelteon administered daily compared to placebo on Sleep Latency in pediatric and adolescent patients between the ages of 2-17.

View Trial
Sjögren Syndrome - RESOLVE

The purpose of the study is to evaluate the impact of RSLV-132 on dryness, tiredness/fatigue and pain in female participants with primary Sjögren's syndrome (pSS) with moderate to severe symptom burden and to assess its safety and tolerability.

View Trial
Asthma Clinical Trial - FLASH

The purpose of this study to Assess Efficacy and Safety of Multiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Uncontrolled Asthma

View Trial
Adults with Moderate-to-Severe Plaque Psoriasis and Obesity

This study to see if weight loss improves plaque psoriasis

View Trial

Sign-Up, Make an Appointment, or Receive More Information

Thank you for your interest in our clinical research trials. Please enter your contact information below and someone will reach out to you shortly to see if you qualify. You can also call us at 1-800-785-3150 or email participate@onsiteclinical.com

By submitting this form, you are consenting to receive marketing emails from: OnSite Clinical Solutions, LLC, 11220 Elm Lane Suite 200 Charlotte, NC 28277, and will be able to revoke your consent to receive emails at any time.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.